Teva Pharmaceutical's (TEVA) Erez Vigodman on 2016-2019 Preliminary Financial Outlook (Transcript)

Teva Pharmaceutical Industries Limited (NYSE:TEVA)

2016-2019 Preliminary Financial Outlook Conference

July 13, 2016, 08:00 AM ET

Executives

Kevin C. Mannix - Senior Vice President of Investor Relations

Erez Vigodman - President, Chief Executive Officer and Director

Eyal Desheh - Chief Financial Officer and Group Executive Vice President

Sigurdur Oli Olafsson - Chief Financial Officer and President-Global Generic Medicines Group

David Stark - Deputy General Counsel

Analysts

Ken Cacciatore - Cowen & Co. LLC

Umer Raffat - Evercore ISI

Liav Abraham - Citigroup Global Markets, Inc.

Jami Rubin - Goldman Sachs & Co.

Manoj Garg - ABR-Healthco

David Risinger - Morgan Stanley & Co. LLC

Timothy Chiang - BTIG LLC

Marc Goodman - UBS Securities LLC

Erica Kazlow - Sanford C. Bernstein & Co. LLC

Randall Stanicky - RBC Capital Markets

David Maris - Wells Fargo Securities LLC

Gregory Fraser - Deutsche Bank Securities, Inc.

Elliot Wilbur - Raymond James & Associates, Inc.

David Amsellem - Piper Jaffray & Co.

Rohit Vanjani - Oppenheimer & Co.

Andrew Finkelstein - Susquehanna Financial Group

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.